In terms of specific strategies, the company will focus on the research and development of innovative drugs and the secondary development of main varieties to strengthen key categories; innovate marketing mechanisms and models to ensure sustained and rapid sales growth; control and operate traditional Chinese medicine resources; Create a digital modern Chinese medicine manufacturing system; build a leading pharmaceutical business enterprise in Sichuan and Chongqing; promote Chinese medicine culture and shape the image of a leading Chinese medicine brand; create a Tai Chi-specific health and wellness platform; standardize governance and enhance the company's overall organizational strength; improve financial operations and capital operation levels , Promote the company's leap-forward development.
In its planning, Taiji Group ranked technological innovation at the top of its corporate development strategy and as an important means to promote high-quality corporate development.
In terms of traditional Chinese medicine resources, the company will scientifically lay out "dual bases" (medicine planting and processing bases) that comply with GACP specifications and full traceability requirements, and take the initiative from the source of traditional Chinese medicine resources. Give full play to the advantages of resources and market analysis and judgment, and implement large-variety operations. Actively promote the industrialization of artificial cultivation of Cordyceps sinensis. At the same time, focusing on Sichuan and Chongqing, we will actively transform, accelerate the construction of a global digital integrated marketing platform, accelerate terminal layout, and create a regional pharmaceutical business leader.
In terms of the big health and wellness platform, under the guidance of "Healthy China", with the help of the e-commerce model, upstream and downstream integration, and import and export integration, the company strives to create a Taiji health and wellness system with the cultural connotation of traditional Chinese medicine and become a Taiji Group develops new growth points by leaps and bounds. The company will also further enrich Taiji's health and wellness products, and leverage Taiji's rich tonic product resources and Sinopharm's advantageous import resources to establish and improve tonic Chinese patent medicines, medicinal and food homologous traditional Chinese medicine pieces and formula granules, and intelligent wearable medical equipment. , health food, special medical food, traditional Chinese medicine daily chemicals, light medical beauty products and biological health products and other large health and wellness product libraries.
In terms of capital operation, Taiji Group will promote capital increase and share expansion, introduce development funds, reduce the asset-liability ratio; and actively seek mergers and acquisitions and restructuring of outstanding enterprises in the industry. Introduce strategic investors, implement capital market refinancing, and actively promote strategic product research and development, intelligent manufacturing upgrades, and mergers and acquisitions of target companies. During the "14th Five-Year Plan" period, complete the optimized disposal and rational operation of "two non" enterprises (non-main businesses and strong non-profit capabilities), idle or low-efficiency assets.